¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"twin reversed arterial perfusion sequence"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • rapid-sequence intubation
    ºü¸¥¿¬¼Ó±â°ü»ð°ü
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
  • respiratory sequence
    È£Èí¼ø¼­
  • radio frequency pulse sequence
    °íÁÖÆÄÆÞ½º¿¬¼â
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • sequence
    1. ¼ø¼­ 2. ¼­¿­ 3. ¿¬¼â
  • signal sequence
    ½ÅÈ£¼ø¼­
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
  • ventilation perfusion inequality
    ȯ±â°ü·ùºñºÒ±Õµî
  • ventilation perfusion mismatch
    ȯ±â°ü·ùºÒ±ÕÇü
  • ventilation perfusion ratio
    ȯ±â°ü·ùºñ
  • whole body perfusion
    Àü½Å°ü·ù, ¿Â¸ö°ü·ù
  • arterial blood
    µ¿¸ÆÇ÷¾×, µ¿¸ÆÇÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • perfusion
    °ü·ù, °üÇ÷·ù
  • perfusion pressure
    °ü·ù¾Ð
  • perfusion rate
    °ü·ù¼Óµµ, °ü·ùÀ²
  • perfusion scan
    °ü·ù½ºÄµ
  • pressure-perfusion study
    ¾Ð·Â°ü·ù°Ë»ç
  • pulmonary perfusion scan
    ÇãÆÄ°ü·ù½ºÄµ, Æó°ü·ù½ºÄµ
  • whole body perfusion
    Àü½Å°ü·ù, ¿Â¸ö°ü·ù
  • ventilation perfusion ratio
    ȯ±â°ü·ùºñ
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¼ø¼­
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • driven equilibrium Fourier transform sequence
    ÃßÁøÆòÇüǪ¸®¾îº¯È¯¿¬¼â
  • echo train sequence
    ¿¡ÄÚ¿­¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ±â¿ï±âȸº¹¿¬¼â
  • flow compensated pulse sequence
    È帧º¸»óÆÞ½º¿¬¼â
  • flow sensitive gradient echo sequence
    È帧¹Î°¨±â¿ï±â¸Þ¾Æ¸®¿¬¼â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • arterial embolic abscess
    µ¿¸Æ»öÀü(¼º) ³ó¾ç.
  • arterial embolism
    µ¿¸Æ»öÀüÁõ.
  • arterial embolism
    µ¿¸Æ »öÀüÁõ(ÔÑØæßáîûñø).
  • arterial filter
    µ¿¸ÆÇ÷¿©°ú.
  • arterial hemorrhage
    µ¿¸Æ(¼º) ÃâÇ÷.
  • arterial hypertension
    µ¿¸Æ(¼º) °íÇ÷¾Ð(Áõ).
  • arterial hypoxia
    µ¿¸Æ(¼º) Àú»ê¼ÒÁõ.
  • arterial hypoxia
    µ¿¸Æ(¼º) Àú»ê¼ÒÁõ
  • arterial injection
    µ¿¸ÆÁÖ»ç.
  • arterial insufficiency
    µ¿¸ÆºÎÀüÁõ.
  • arterial lesion
    µ¿¸Æ(¼º) º´º¯.
  • arterial murmur
    µ¿¸ÆÀâÀ½.
  • arterial nephrosclerosis
    µ¿¸Æ¼º ½Å°æÈ­Áõ.
  • arterial network
    µ¿¸Æ±×¹°
  • arterial occlusion
    µ¿¸ÆÆó¼â.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • ventilation/perfusion ratio
    ȯ±â/°ü·ùºñ
  • whole body perfusion
    Àü½Å°ü·ù(îïãóδêü).
  • acardiac twin
    ¹«½ÉÀå½ÖžÆ
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • asymmetric twin
    ºñ´ëνÖžÆ
  • binovular twin
    À̶õ¼º ½Ö»ý¾Æ(¡­äªßæä®).
  • biovular twin
    À̶õ¼º ½Ö»ý¾Æ(ì£Õ°àõäªßæä®).
  • breech disruption sequence
  • co-twin
    ½ÖµÕÀÌ ÇÑÂÊ ¡ì½ÖµÕÀÌ ÁßÀÇ ÇÑ»ç¶÷¡í.
  • conjoined twin
    À¯ÇÕ½ÖžÆ.ÇØºÎ°áÇÕ½ÖžÆ, ¿¬ÇÕ½Ö»ý¾Æ(¡­äªßæä®).
  • conjoined twin
    °áÇÕ½ÖžÆ
  • conjoined twin
    °áÇÕ½Ö¹èÀÚ
  • delta sequence
    µ¨Å¸ ¼­¿­
  • diamniotic twin
    2¾ç¸·½Ö»ý¾Æ(ì£åÏØ¯ äªßæä®).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
CTPP cerebral tissue perfusion pressure
HPI hepatic perfusion index; history of present illness
MPI mannose phosphate isomerase; master patient index; maximum permitted intake; maximum point of impuls...
MPS meconium plug syndrome; medial premotor system; Member of the Pharmaceutical Society; microbial prof...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CHPP Continuous hyperthermic peritoneal perfusion
CPP Coronary Perfusion Pressure
DPI Doppler Perfusion Index
HPI Hepatic Perfusion Index
HAP Hyperthermic Antiblastic Perfusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • arterial wave
    µ¿¸Æ ÆÄ
  • effective arterial volume
    À¯È¿ µ¿¸ÆÇ÷·®
  • intra-arterial
    µ¿¸Æ³»ÀÇ
  • intra-arterial injection
    µ¿¸Æ³» ÁÖ»ç
  • obliterative arterial disease
    Æó»ö¼º µ¿¸Æ Áúȯ
  • percutaneous femoral arterial puncture
    °æÇÇÀû ´ëÅ𠵿¸Æ õÀÚ
  • pulmonary arterial hypertension
    Æó ¼øÈ¯ ½Â¾Ð
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö
  • transcatheter arterial embolization
    °æµµ°ü µ¿¸Æ »öÀü¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
canonical sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
carbohydrate sequence The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids.
(12 Dec 1998)
palindromic sequence <molecular biology> Nucleic acid sequence that is identical to its complementary strand when each is read in the correct direction (e.g. TGGCCA). Palindromic sequences are often the recognition sites for restriction enzymes. Degenerate palindromes with internal mismatching can lead to loops or hairpins being formed (as in tRNA).
(18 Nov 1997)
recognition sequence A nucleotide sequence --typically composed of 4, 6, or 8nucleotides -- that is recognised by a restriction endonuclease. Type II enzymes cut (and theircorresponding modification enzymes methylate) within or very near the recognition sequence.
(09 Oct 1997)
regulatory sequence <molecular biology> DNA sequence to which regulatory molecules such as promotors or enhancers bind, thereby altering the expression of the adjacent gene.
(18 Nov 1997)
centromeric sequence <molecular biology> Special sequences of DNA nucleotides found on chromosomes which provide a site for the attachment of spindle fibres during nuclear division (mitosis or meiosis).
(09 Oct 1997)
chi sequence <molecular biology> A specific sequence of nucleotides on a site on the genome of the bacteria Escherichia coli which strongly encourages recombination and crossing over to occur at that site.
(05 Jan 1998)
PEST sequence Amino acid motif that is thought to target cytoplasmic proteins for rapid proteolytic degradation.
(18 Nov 1997)
molecular sequence data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories.
(12 Dec 1998)
coding sequence The portion of DNA that codes for transcription of messenger RNA.
See: exon.
(05 Mar 2000)
monotonic sequence A sequence in which each value in a set is greater than the preceding value.
(05 Mar 2000)
complementary sequence <molecular biology> Nucleicacid base sequences that can form a double-stranded structure bymatching base pairs, the complementary sequence to G-T-A-C is C-A-T-G.
(09 Oct 1997)
consensus sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
conserved sequence <molecular biology> A base sequence in a DNA molecule (or an amino acid sequence in a protein) that has remained essentially unchanged throughout evolution.
(10 Nov 1998)
sequence The noun: the order in which subunits appear in a chain, such as amino acids in a polypeptide or nucleotide bases in a DNA or RNA molecule.
The verb: To find out in what order the subunits appear in the chain.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á